MBX 2109
Phase 2- Indications
- Hypoparathyroidism
Company intelligence / Profile preview
Marcadia Biotech
Carmel, Indiana, USAprofiles.biocentury.com ↗
- Ownership
- Private
- Employees
- ~12
- Development stage
- Phase 2
01
Overview
Marcadia developed a robust pipeline of novel peptide drug candidates targeting type 2 diabetes, obesity, and severe hypoglycemia. The company’s lead assets included a glucagon analog for acute hypoglycemia and dual agonist peptides with potentially superior profiles compared to marketed drugs. Clinical results were not publicly detailed before the Roche acquisition; the company was considered promising based on preclinical and early clinical data.
- Therapeutic areas
- Endocrinology
- Modalities
- Peptide therapeuticspeptide analogs
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Merck & Co., Inc.: Strategic R&D partnership/licensing deal focused on novel biopharmaceutical therapies targeting glucagon-related receptors for diabetes/obesityIndiana University Research & Technology Corporation/IU Chemistry Department—licensing IP/sponsored research agreements
Beyond the preview
Go deeper on Marcadia Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Marcadia Biotech.